Fuyuki Kametani

9.7k citations

196 papers · 6.6k indexed · 4 hit papers · h-index 39

Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 22
- Amyotrophic Lateral Sclerosis Research 16
Physiology top 0.5%
- Alzheimer's disease research and treatments 80
Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments 22
- Amyotrophic Lateral Sclerosis Research 16
Genetics top 1%
Biological Psychiatry top 5%
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 59
- Prion Diseases and Protein Misfolding 30
- Protein Interaction Studies and Fluorescence Analysis 13
Pharmacology
- Cholinesterase and Neurodegenerative Diseases 19
Oncology
- Drug Transport and Resistance Mechanisms 11

Co-authors: Masato Hasegawa Haruhiko Akiyama Takashi Nonaka Mari Yoshida Tetsuaki Arai Shuji Kitagawa Shigeo Murayama Shu‐ichi Ikeda
Cited by: Neurology Physiology
Journals: Nature (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (5 papers)
Partner nations: Japan United Kingdom United States

In The Last Decade

Fuyuki Kametani

190 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Fuyuki Kametani

Since Specialization

Citations

This map shows the geographic impact of Fuyuki Kametani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyuki Kametani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyuki Kametani more than expected).

Fields of papers citing papers by Fuyuki Kametani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyuki Kametani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyuki Kametani. The network helps show where Fuyuki Kametani may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fuyuki Kametani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fuyuki Kametani Line = papers co-authored together Fuyuki Kametani links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Amyloid-Forming Corpora Amylacea and Spheroid-Type Amyloid Deposition: Comprehensive Analysis Using Immunohistochemistry, Proteomics, and a Literature Review Preprints.org ·Shojiro Ichimata,Yukiko Hata,Tsuneaki Yoshinaga,Nagaaki Katoh,Fuyuki Kametani,Masahide Yazaki,Yoshiki Sekijima,Naoki Nishida	2024	1
2	Enterocolic granulomatous phlebitis associated with epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 deposition and focal amyloid properties: A case report Pathology International ·Shojiro Ichimata,Akane Aikawa,Naonori Sugishita,Nagaaki Katoh,Fuyuki Kametani,H Tagawa,Yusuke Handa,Masahide Yazaki,Yoshiki Sekijima,Takashi Ehara,Naoki Nishida,Shin Ishizawa	2024	4
3	Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G Acta Neuropathologica ·Chao Qi,Ryota Kobayashi,Shinobu Kawakatsu,Fuyuki Kametani,Sjors H. W. Scheres,Michel Goedert,Masato Hasegawa	2024	5
4	TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP Nature ·Diana Arseni,Renren Chen,Alexey G. Murzin,Sew‐Yeu Peak‐Chew,Holly J. Garringer,Kathy L. Newell,Fuyuki Kametani,Andrew Robinson,Rubén Vidal,Bernardino Ghetti,Masato Hasegawa,Benjamin Falcon	2023	72
5	Distinct tau folds initiate templated seeding and alter the post-translational modification profile Brain ·Airi Tarutani,Fuyuki Kametani,Marina Tahira,Yuko Saito,Mari Yoshida,Andrew Robinson,David M. A. Mann,Shigeo Murayama,Taisuke Tomita,Masato Hasegawa	2023	8
6	Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia Antioxidants ·Wataru Araki,Fuyuki Kametani	2022	12
7	Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer’s disease Neuroscience Research ·Kaori Taniguchi,Fumiko Yamamoto,Akiko Amano,Akira Tamaoka,Nobuo Sanjo,Takanori Yokota,Fuyuki Kametani,Wataru Araki	2022	25
8	Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture Cells Neurochemical Research ·Takuto Shimizu,Emiko Nogami,Yuka Ito,Kazuo Morikawa,Masaki Nagane,Tadashi Yamashita,Tsuyoshi Ogawa,Fuyuki Kametani,Hisashi Yagi,Naomi Hachiya	2021	4
9	Structure of pathological TDP-43 filaments from ALS with FTLDbreakdown → Nature ·Diana Arseni,Masato Hasegawa,Alexey G. Murzin,Fuyuki Kametani,Makoto Arai,Mari Yoshida,Benjamin Falcon	2021	180
10	TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons Neuroscience ·Fumiko Yamamoto,Kaori Taniguchi,Naomi Mamada,Akira Tamaoka,Fuyuki Kametani,Madepalli K. Lakshmana,Wataru Araki	2019	17
11	Comprehensive proteomic profiles of mouse AApoAII amyloid fibrils provide insights into the involvement of lipoproteins in the pathology of amyloidosis Journal of Proteomics ·Hiroki Miyahara,Jinko Sawashita,Eri Ishikawa,Mu Yang,Xin Ding,Yingye Liu,Naomi Hachiya,Fuyuki Kametani,Masahide Yazaki,Masayuki Mori,Keiichi Higuchi	2017	14
12	Long‐term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice Neuropathology ·Haruhiko Akiyama,Masato Hosokawa,Fuyuki Kametani,Hiromi Kondo,Momoko Chiba,Masako Fukushima,Takeshi Tabira	2011	27
13	MEK inhibitors suppress β‐amyloid production by altering the level of a β‐C‐terminal fragment of amyloid precursor protein in neuronal cells FEBS Letters ·Wataru Araki,Fuyuki Kametani,Akiko Oda,Akira Tamaoka	2010	5
14	Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisbreakdown → Annals of Neurology ·Masato Hasegawa,Tetsuaki Arai,Takashi Nonaka,Fuyuki Kametani,Mari Yoshida,Yoshio Hashizume,Thomas G. Beach,Emanuele Buratti,Francisco E. Baralle,Mitsuya Morita,Imaharu Nakano,Tatsuro Oda,Kuniaki Tsuchiya,Haruhiko Akiyama	2008	592
15	Reticulons RTN3 and RTN4‐B/C interact with BACE1 and inhibit its ability to produce amyloid β‐protein European Journal of Neuroscience ·Kiyoko S. Murayama,Fuyuki Kametani,Shinya Saito,Hideaki Kume,Haruhiko Akiyama,Wataru Araki	2006	106
16	Human wild presenilin-1 mimics the effect of the mutant presenilin-1 on the processing of Alzheimer's amyloid precursor protein in PC12D cells Journal of the Neurological Sciences ·Fuyuki Kametani,Kikuko Tanaka,Mihoko Usami,Kei Maruyama,Hiroshi Mori	2001	1
17	Secretory Form of Alzheimer Amyloid Precursor Protein 695 in Human Brain Lacks β/A4 Amyloid Immunoreactivity Biochemical and Biophysical Research Communications ·Fuyuki Kametani,Kunihito Tanaka,Tsuyoshi Ishii,S. Ikeda,H.E. Kennedy,David Allsop	1993	37
18	Inhibitory effects of catechol derivatives on arachidonic acid-induced aggregation of rabbit platelets. Chemical and Pharmaceutical Bulletin ·Shuji Kitagawa,H Fujisawa,Seiki Baba,Fuyuki Kametani	1991	6
19	Asymmetry of membrane fluidity in the lipid bilayer of blood platelets: Fluorescence study with diphenylhexatriene and analogs The Journal of Membrane Biology ·Shuji Kitagawa,Masako Matsubayashi,Kazuo Kotani,Koji Usui,Fuyuki Kametani	1991	56
20	Comparative studies on the structure of the light chains of human immunoglobulins. IV. Assignment of a subsubgroup.:IV. Assignment of a Subsubgroup The Journal of Biochemistry ·Fuyuki Kametani,Tatsunori Takayasu,Satoru Suzuki,Tomotaka Shinoda,Tsuneo Okuyama,Akira Shimizu	1983	11

About Fuyuki Kametani

Fuyuki Kametani is a scholar working on Physiology, Neurology and Molecular Biology, having authored 196 papers that have together received 6.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (80 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers), Prion Diseases and Protein Misfolding (30 papers), Parkinson's Disease Mechanisms and Treatments (22 papers), Cholinesterase and Neurodegenerative Diseases (19 papers), Amyotrophic Lateral Sclerosis Research (16 papers), Protein Interaction Studies and Fluorescence Analysis (13 papers) and Drug Transport and Resistance Mechanisms (11 papers). The work is most often cited by research in Neurology (2.2k citations), Physiology (3.1k citations) and Neurology (787 citations). Fuyuki Kametani has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Masato Hasegawa, Haruhiko Akiyama, Takashi Nonaka, Mari Yoshida, Tetsuaki Arai, Shuji Kitagawa, Shigeo Murayama, Shu‐ichi Ikeda, Alexey G. Murzin and Masahide Yazaki. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact